Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : GREAT STOCKS UNDER $15 -- Ignore unavailable to you. Want to Upgrade?

To: AV8R who wrote (34)	12/5/1998 11:08:00 PM
From: Ed Silverstein	Read Replies (2) \| Respond to of 126

WCTI - say no more!!!

To: AV8R who wrote (34)	12/6/1998 9:59:00 AM
From: Arthur Radley	Respond to of 126

I would like to offer the following stock to the mix: SUMX #reply-6520061 Here are some additional valuation multiples to consider for them in comparison to S&P companies. Price to Cash Flow Sumx-5.7x S&P-22.7x Price to Free Cash Flow SUMX-8.7x S&P-46.2x Price to Sales SUMX-0.5x S&P-4.4x Price to Book SUMX 1.6 S&P -7.9x Price to Tangible Book SUMX 4.5x S&P 11.4 This information obtained from Charles Schwab/Market Guide SUMX will have its annual stock holder meeting this week(Dec 10) and should report first Q earnings within two weeks.

To: AV8R who wrote (34)	12/6/1998 12:38:00 PM
From: Street Walker	Respond to of 126

KERA - technicals iqc.com KERA had strength at $9.50 for a long time. Look at the shocastics during that period. Then it made a huge jump. It made a retracement on Friday, tested a support area and rapidly rebounded. Look at the current schocastics on the above chart. They are in the low range which signifies oversold, and are trending up, which signifies it is about to make another huge jump. All of this combined shows strength. Then you combine the FDA meeting on January 12 and buyers coming in in anticipation, and you have a winner. I would bet that the majority of stock holders are opthamologists. These type of individuals most likely bought for the long term. They have vision<g>. Myself, I'm in for the short term. After the FDA approval and some media attention, it is going to skyrocket. That is the time for short term investors to sell. This is what the KeraVision Ring looks like: (great place to study about the technology) keravision.com Regards, S.W.